Tumor Lysis Syndrome Occurring After the Administration of Rituximab for Posttransplant Lymphoproliferative Disorder

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1946-1948

  Francescone, S A ^a   Murphy, B ^a   Fallon, J T ^a   Hammond, K ^a   Pinney, S ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIBIOTIC AGENT; AZATHIOPRINE; CLOPIDOGREL; CYCLOSPORIN; CYCLOSPORIN A; RAPAMYCIN; RITUXIMAB; SIMVASTATIN;

ADULT; ANGIOGRAPHY; ANURIA; ARTICLE; ARTIFICIAL VENTILATION; BARE METAL STENT; BONE MARROW BIOPSY; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; COUGHING; DEFIBRILLATOR; DISEASE COURSE; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; EPSTEIN BARR VIRUS; GLOMERULOSCLEROSIS; GRAFT RECIPIENT; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; KIDNEY BIOPSY; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; METABOLIC ACIDOSIS; MORTALITY; NEPHROSCLEROSIS; PANCYTOPENIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SINGLE DRUG DOSE; STENOSIS; SUDDEN DEATH; SYNCOPE; TUMOR LYSIS SYNDROME; VASCULAR DISEASE;

ANTIBODIES, MONOCLONAL; CARDIOMYOPATHY, DILATED; ELECTRIC COUNTERSHOCK; FATAL OUTCOME; HEART TRANSPLANTATION; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS; TUMOR LYSIS SYNDROME;

EID: 67249166261     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.060     Document Type: Article

References (6)

1. Yang H., Rosove M.H., and Figlin R.A. Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Am J Hematol 62 (1999) 247
2. Jensen M., Winkler U., Manzke O., et al. Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab). Ann Hematol 77 (1998) 89
3. Scott S.D. Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma. Cancer Pract 6 (1998) 195
4. Reff M.E., Carner K., Chambers K.S., et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83 (1994) 435
5. Jabr F.I. Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma. Int J Hematol 82 (2005) 312
6. Abou Mourad Y., Taher A., and Shamseddine A. Acute tumor lysis syndrome in large B-cell non- Hodgkin lymphoma induced by steroids and anti-CD 20. Hematol J 4 (2003) 222